In-Vitro Toxicology/Toxicity Testing Market is Expected to Grow at a CAGR of 9% From 2019 to Reach $14.4 Billion by 2025 | Meticulous Research

Meticulous Research – a leading global market research company published a research report titled “In-Vitro Toxicology/Toxicity Testing Market by Product& Service, Technology (Cell Culture, OMICS), Method (Cell-based Assays, In-Silico), End-point (ADME, Genotoxicity, Organ Toxicity, Dermal Toxicity), End-user, and Geography – Global Forecast to 2025”.

According to this latest publication from Meticulous Research®, the global in-vitro toxicology testing market is expected to grow at a CAGR of 9% from 2019 to reach $14.4 billion by 2025.

Download Free Sample Copy Of The Report:: https://www.meticulousresearch.com/download-sample-report/cp_id=5047

 Key questions answered in the report-

Which are the high growth market segments in terms of product & service, technology, method, end-point, end-user, and region/countries?

What was the historical market size for in vitro toxicology testing across the globe?

What are the market forecasts and estimates for the period 2019-2025?

What are the major drivers, restraints, opportunities, and challenges in the global in vitro toxicology testing market?

Who are the major players in the global in vitro toxicology testing market?

How is the competitive landscape and who are the market leaders in the global in vitro toxicology testing market?

What are the recent developments in the global in vitro toxicology testing market?

What are the different strategies adopted by the major players in the global in vitro toxicology testing market?

What are the geographical trends and high growth regions/ countries?

Who are the local emerging players in the global in vitro toxicology testing market and how do they compete with the global players?

Have Any Query? Ask Our Expert https://www.meticulousresearch.com/speak-to-analyst/cp_id=5047

 The growth of this market is driven by factors, such as ethical issues and pressure from animal activists’ groups concerning the use of animals for testing, ban on animal testing on cosmetic products, support from regulatory bodies regarding the approval of in-vitro tests, low costs associated with in-vitro toxicology testing, and advancements in in-vitro methodologies. Moreover, synergetic relationships between various stakeholders in the industry and increasing toxicology databases to facilitate the use of in-vitro test methods are expected to offer significant growth opportunities for the players operating in this market.

The global in-vitro toxicology testing market study presents historical market data in terms of value (2018), estimated current data (2019), and forecasts for 2025-by product & service (equipment, assay kits, consumables, software, services), technology (cell culture technologies, high-throughput screening technologies, OMICS technologies), method (cell-based assays, biochemical assays, in-silico, ex-vivo), end-point (ADME; skin irritation, corrosion, sensitization; genotoxicity; cytotoxicity; ocular toxicity; organ toxicity; phototoxicity; and dermal toxicity), end-user (pharmaceutical & biotechnology industries, cosmetics industry, food industry, and chemical industry). The study also evaluates industry competitors and analyzes the market at a regional and country level.

You Can Directly Buy  This Report From Here:: https://www.meticulousresearch.com/buy_now.php?pformat=348&vformat=1030

(Get key industry insights spread across 189 pages with 120 market data tables & 30 figures & charts from the report)

 On the basis of product, the consumables segment is estimated to dominate the overall in-vitro toxicology testing market in 2019, mainly due to increasing number of in-vitro tests being performed across the globe leading to recurrent purchase of reagents and other labware. However, the software segment is projected to grow at the highest CAGR during the forecast period. The high growth of this segment can be attributed to increasing computer models and algorithms being developed to predict toxicity of test substances.

On the basis of technology, the cell culture technologies segment is estimated to account for the largest share of the in-vitro toxicology testing market in 2019, owing to growing adoption of 3D cell culture and stem cell models for toxicity testing.

On the basis of method, the in-vitro toxicology testing market is sub-segmented into cell-based assays, biochemical assays, in silico testing, and ex vivo testing. Cell-based assays segment is estimated to command the largest share of the in-vitro toxicology testing market in 2019. Advancements in cell-based technologies such as high-content screening and label-free detection are the key factors attributed to the large share of this segment in the overall market.

On the basis of end point, the ADME segment is estimated to account for the largest share of the overall in-vitro toxicology testing market in 2019. This is primarily attributed to the increasing number of early stage in-vitro ADME screening tests to prevent failure at later stage.

On the basis of end user, the in vitro toxicology testing market is segmented into pharmaceutical and biotechnology companies, cosmetics, food industry, and chemical industry. The pharmaceutical and biotechnology companies segment is estimated to account for the largest share of the overall in-vitro toxicology testing market in 2019. This is primarily attributed to increasing drug attrition rates and growing adoption of early in-vitro preclinical safety testing to filter out molecules with a higher potential for toxicity. However, the cosmetics industry segment is expected to grow at a higher rate owing to the ban on use of animals for testing toxicity of cosmetics and its ingredients.

Here are the top Market companies in the world::  https://meticulousblog.org/top-10-companies-in-in-vitro-toxicology-toxicity-testing-market/

Key Players::

In-vitro toxicology testing market is a highly consolidated in nature, wherein 3 major players — Thermo Fisher Scientific (US), Merck (Germany), and GE Healthcare (US) — accounted for major share of the global in-vitro toxicity testing market. Other key players operating in this market are Bio-Rad Laboratories (US), SGS SA (Switzerland), Laboratory Corporation of America Holdings (U.S.), Qiagen N.V. (Netherlands), and Eurofins Scientific (Luxembourg), among others.

Geographical Analysis::

This research report analyzes major geographies and provides comprehensive analysis of Europe (Germany, U.K., France, Italy, Spain, and RoE), North America (U.S., Canada), Asia-Pacific (China, Japan, India,and RoAPAC), Latin America, and Middle East & Africa. Europe commanded the largest share of the global in-vitro toxicology testing market, followed by North America and Asia Pacific (APAC). The large share of this region is mainly attributed to the factors such as ban on animal testing for cosmetics and its ingredients, and government initiatives to promote the reduction of use of animals for toxicity testing. Asia-Pacific region is expected to grow at the highest CAGR during the forecast period of 2019 to 2025, owing to increasing biotech investments in this region and growing collaborations between local and foreign companies.

Download Free Sample Copy Of The Report:: https://www.meticulousresearch.com/download-sample-report/cp_id=5047

 Related Reports::

1Veterinary Immunodiagnostics Market Size by Product (Analysers, Consumables), by technology (ELISA, Radioimmunoassay, Rapid tests, and others), by animal type [Livestock (Cattle, Pigs, Poultry) and Companion (Feline, Canine, Equine)], by application (Infectious diseases, autoimmune disorder, endocrinology & oncology, and bone & mineral diseases), and by End-user – Global Forecasts to 2022

2 Cancer Immunotherapy Market By Type (Monoclonal Antibodies, Checkpoint Inhibitors, Immunomodulators, Vaccines, Cell Therapy), Application (Lung, Breast, Multiple Myeloma, Colorectal, Melanoma, Prostate), and End User- Global Forecast to 2024

3 Competent Cells Market by Type (Cloned Competent Cells, Agrobacterium Tumefaciens Competent Cells, and Expression Competent Cells), Treatment (Chemically Competent Cells and Electrocompetent Cells), Application (Cloning, Protein Expression, others), and by End User (Pharmaceutical and Biotechnology Industry, Academic and Research Institutes, and Contract Research Organizations) – Global Forecasts to 2023

About Meticulous Research®

The name of our company defines our services, strengths, and values. Since the inception, we have only thrived to research, analyze and present the critical market data with great attention to details. Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, with the help of its unique research methodologies, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa regions.

 Contact Us:

Meticulous Research®

Email- sales@meticulousresearch.com

Contact Sales- +1-646-781-8004

Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research

This content has been distributed via WiredRelease press release distribution service. For press release service enquiry, please reach us at contact@wiredrelease.com.